Providing financial relief to cancer patients in Colorado who are struggling to afford their expensive, life-saving medications is a top priority for policymakers across the political spectrum. An important step to enacting substantial cost savings is to reform the anti-patient practices of companies that exert huge control over the prescription drug marketplace. A bipartisan group of U.S. senators is aiming to do just that.
top of page
bottom of page